Literature DB >> 21883707

MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.

K Bektas-Kayhan1, M Unur, Z Boy-Metin, B Cakmakoglu.   

Abstract

AIM: We aimed to investigate a possible association of the MCP-1 and CCR2 polymorphisms with the risk of developing oral squamous cell carcinoma (OSCC).
METHODS: MCP-1 A2518G and CCR2 V64I gene polymorphisms were performed by polymerase chain reaction and restriction fragment length polymorphism, in 129 patients with OSCC and 140 healthy control subjects.
RESULTS: Individuals who had G allele and GG genotype of MCP-1, and 64I allele and wt/64I genotype of CCR2 had increased risk for OSCC (P<0.05.) In contrast, individuals with CCR2 wt/wt genotype seem to be protected from OSCC (P < 0.01). Haplotype analysis revealed that MCP-1G: CCR2 64I haplotype frequencies were significantly higher in patients than those of controls (P = 0.001).
CONCLUSIONS: We can suggest that the G allele of MCP-1 and 64I allele of CCR2 may be risk factors for OSCC.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883707     DOI: 10.1111/j.1601-0825.2011.01843.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  7 in total

Review 1.  Updated overview of current biomarkers in head and neck carcinoma.

Authors:  Kiran Dahiya; Rakesh Dhankhar
Journal:  World J Methodol       Date:  2016-03-26

2.  Impact of CCL2 and Its Receptor CCR2 Gene Polymorphism in North Indian Population: A Comparative Study in Different Ethnic Groups Worldwide.

Authors:  Vibha Singh; Neena Srivastava; Priyanka Srivastava; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2012-10-05

3.  Distribution of monocyte chemoattractant protein-1 (MCP-1 A-2518G) and chemokine receptor (CCR2-V64Ι) gene variants in hyperbilirubinemic newborns.

Authors:  Fatma Narter; Elif Sinem Bireller; Can Engin; Tolga Catmakas; Fehmi Narter; Arzu Ergen; Bedia Cakmakoglu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Association between MCP-1 -2518A/G polymorphism and cancer risk: evidence from 19 case-control studies.

Authors:  Liang-Shan Da; Ying Zhang; Shuai Zhang; Yi-Chun Qian; Qin Zhang; Feng Jiang; Lin Xu
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

5.  Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.

Authors:  Teresa Magnes; Thomas Melchardt; Lukas Weiss; Christof Mittermair; Daniel Neureiter; Eckhard Klieser; Simon Gampenrieder; Gerhard Moser; Alexander Gaggl; Richard Greil; Alexander Egle
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

6.  CCL2 Serum Levels and Adiposity Are Associated with the Polymorphic Phenotypes -2518A on CCL2 and 64ILE on CCR2 in a Mexican Population with Insulin Resistance.

Authors:  Milton-Omar Guzmán-Ornelas; Marcelo Heron Petri; Mónica Vázquez-Del Mercado; Efraín Chavarría-Ávila; Fernanda-Isadora Corona-Meraz; Sandra-Luz Ruíz-Quezada; Perla-Monserrat Madrigal-Ruíz; Jorge Castro-Albarrán; Flavio Sandoval-García; Rosa-Elena Navarro-Hernández
Journal:  J Diabetes Res       Date:  2015-12-29       Impact factor: 4.011

7.  Monocyte Chemoattractant Protein-1 in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Biomarker Potential and Association with Polymorphisms in the MCP-1 and the CC Chemokine Receptor-2 Gene.

Authors:  Nina Jönsson; Evelina Erlandsson; Lena Gunnarsson; Åsa Pettersson; Sophie Ohlsson
Journal:  Mediators Inflamm       Date:  2018-03-12       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.